Announcement, Cancer Research Heroes 03.27.23 Share on Twitter Share on Facebook Share on LinkedIn Special Event Celebrates Career of PICI Center Director Carl H. June, MD PICI hosts film screening, Q&A in honor of the CAR T-cell research pioneer SAN FRANCISCO – The Parker Institute for Cancer Immunotherapy (PICI) hosted a special event March 11 celebrating Carl H. June, MD, center director of PICI at the University of Pennsylvania, and his groundbreaking work and career. More than 500 people attended the gathering at the Presidio Theatre, which included a screening of the critically acclaimed documentary, “Of Medicine and Miracles.” The feature-length film depicts Dr. June’s pioneering research and its lifesaving effect on 6-year-old Emily Whitehead, the first pediatric patient in the world to receive chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory acute lymphoblastic leukemia (ALL). After the screening, PICI Founder and Chairman Sean Parker moderated a lively Q&A featuring Dr. June and his research partner Dr. Bruce Levine, as well as Ross Kauffman, the film’s Academy Award-winning director. We want to thank everyone who joined us in recognizing Dr. June and his pioneering career. Thanks, also, to those who donated to support the event, particularly PICI Board Member Jeff Huber and his company Triatomic Capital. For email updates about future events and other news, register here. Please consider supporting our mission by donating here. Related Announcement, Press Release Parker Institute Welcomes New Co-Directors for PICI Centers at Stanford, UCSF & Penn Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators
Announcement, Press Release Parker Institute Welcomes New Co-Directors for PICI Centers at Stanford, UCSF & Penn
Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer
Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators